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Metabolic and Toxicological Effects of Water-Soluble 
Xenon Compounds Are Studied 
Since the recent discovery of water-soluble xenon 
compounds, there has been much interest in their 
biological properties. Metabolic and toxicological 
studies have been conducted on mice, which extend 
the scientific knowledge of these rare gases. 
The primary features of these studies on the 
biology of water-soluble xenates were: (a) the 
moderate toxicity of these substances, (b) their rapid 
decomposition in the body, (c) the speed with which 
the xenate appeared to be reduced to xenon gas, and 
(d) the very rapid elimination of this gas from the 
body. 
For this research, the mice were injected intra-
venously and intraperitoneally with aqueous solutions 
of sodium xenate. When injected intravenously, the 
sodium xenate was found to be moderately toxic. The 
median lethal dose was between 15 and 30 mg/kg. 
Early deaths were preceded by marked convulsions 
and tetanic contractions, while those that occurred 
later were characterized by a deepening comatose 
state. 
Radioactive labelled sodium xenate also was in-
jected into the mice and the retention of the xenon 
formed was studied. Intravenously injected sodium 
xenate left the body very quickly, presumably after 
reduction to xenon gas. The peak value was reduced 
to 507. within 20 seconds and to 20% in 75 seconds. 
Intraperitoneally injected sodium xenate left the 
body more slowly. A value half that of the peak was 
reached in six minutes.
Notes: 
I. The information should be of interest to physiol-
ogists and others engaged in studying the effects 
of rare gases on life systems. 
2. Additional details are contained in: Noble Gas 
Compounds, edited by H. H. Hyman, Univ. of 
Chicago Press, Chicago, London; Univ. of Toronto 
Press, Toronto 5, Canada: Library of Congress 
Catalog Card #63-20907, 1963, p. 309-314. 
3. Inquiries concerning this innovation may be di-
rected to:
Office of Industrial Cooperation 
Argonne National Laboratory 
9700 South Cass Avenue 
Argonne, Illinois 60439 
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Source: A. J. Finkel, C. E. Miller, 
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and J. J. Katz, 
Chemistry Division 
(A RG-90239) 
Patent status: 
Inquiries about obtaining rights for commercial use 
of this innovation may be made to: 
Mr. George H. Lee, Chief 
Chicago Patent Group 
U.S. Atomic Energy Commission 
Chicago Operations Office 
9800 South Cass Avenue 
Argonne, Illinois 60439
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